| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 22 | 13 | 28 |
| Total Expenses - EUR | 0 | 40 | 39 | 36 | 130 | 47 | 0 | 2.604 | 165 | 281 |
| Gross Profit/Loss - EUR | 0 | -40 | -39 | -36 | -130 | -47 | 0 | -2.582 | -151 | -253 |
| Net Profit/Loss - EUR | 0 | -40 | -39 | -36 | -130 | -47 | 0 | -2.582 | -151 | -253 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Dialmed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 16.268 | 16.102 | 15.830 | 15.539 | 15.238 | 14.949 | 14.618 | 14.663 | 14.619 | 114.386 |
| Current Assets | 53 | 48 | 52 | 47 | 46 | 2 | 143 | 0 | 0 | 30 |
| Inventories | 48 | 47 | 47 | 46 | 45 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 5 | 0 | 5 | 2 | 1 | 2 | 143 | 0 | 0 | 30 |
| Shareholders Funds | -2.335 | -2.351 | -2.350 | -2.343 | -2.427 | -2.428 | -2.374 | -4.963 | -5.100 | 94.524 |
| Social Capital | 225 | 223 | 219 | 215 | 211 | 207 | 202 | 203 | 202 | 201 |
| Debts | 20.273 | 20.224 | 19.999 | 19.760 | 19.614 | 19.532 | 19.472 | 19.627 | 19.719 | 19.892 |
| Income in Advance | 13 | 24 | 24 | 23 | 23 | 22 | 22 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "5146 - 5146" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Dialmed Srl